Earnings Call · Q1 FY2025·2025-04-15

Q1 25EPS +7.36%·Rev n/aQ4 24EPS +1.49%·Rev n/aQ3 24EPS +9.50%·Rev n/aQ2 24EPS +4.44%·Rev n/a⚠ consensus missing

JOHNSON & JOHNSON JNJ

Jessica Moore — Vice President, Investor Relations

Joaquin Duato — Chairman and Chief Executive Officer

John Reed — Executive Vice President, Pharmaceuticals, Chief Scientific Officer

Joe Wolk — Executive Vice President, Chief Financial Officer

−0.5%1d on move date−0.2% vs SPY3d+2.0%5d+2.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more JNJ calls or request research access.

More JNJ calls Browse calls Request research access